Mission Statement
Who We Are
5-Year Strategic Plan
Useful Links:
Food Animal
Residue Avoidance Databank (FARAD)
Cooperative Project for Approval of Drugs for Minor Species and Minor Uses in
other Species, NRSP-7
Co-Chairs:
| Kevin J.Greenlees USFDA/CVM HFV-153, 7500 Standish Place Rockville, MD 20855 Phone: 301-827-6977 FAX: (301) 594-2298 Email: kevin.greenlees@fda.hhs.gov |
Gary L. Jensen National Program Leader-Aquaculture USDA/CSREES STOP 2220, 1400 Independence Ave, SW Washington, DC 20250-2220 Phone: (202) 401-6802 FAX: (202) 401-6156 Email: gjensen@csrees.usda.gov |
To increase understanding of, and compliance with, Federal requirements regarding drugs, chemicals, and biologics used in aquaculture production in the United States through education and coordination of efforts of government, industry, and academia, related to the development and implementation of quality assurance programs.
The Working Group for Quality Assurance in Aquaculture Production was formed in 1990 and is one of the original working groups of the federal Joint Subcommittee on Aquaculture.
In 2006, the name of the Working Group was changed to: Working Group on Aquaculture Drugs, Biologics, and Pesticides. The group was originally chaired by Gary Stefan of the US Food and Drug Administration's Center for Veterinary Medicine. The Working Group is currently co-chaired by Kevin Greenlees (Food and Drug Administration, Center for Veterinary Medicine) and Gary Jensen (US Department of Agriculture's Cooperative States Research, Education and Extension Service. While co-chaired by representatives of federal agencies, the membership includes federal, state, industry, and academic representatives. The Working Group was formed in response to federal interagency recognition of the need for education and outreach to the developing aquaculture community. he original focus was on assuring a quality product produced by the aquaculture industry and much of the early work was with industry groups in developing quality assurance programs. As this work progressed, there was early recognition that the development of a quality product required adequate tools, and that there was a need to address the availability and appropriate use of drugs, chemicals and biologics in aquaculture.This page has been accessed
times since its inception
Last updated on 6/7/2004
For comments contact Max Mayeaux at:
mmayeaux@csrees.usda.gov